Terms: = Liver cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Prognosis
15 results:
1. The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics.
Shen X; Hu B; Xu J; Qin W; Fu Y; Wang S; Dong Q; Qin L
Cancer Biol Med; 2020 Nov; 17(4):937-952. PubMed ID: 33299645
[TBL] [Abstract] [Full Text] [Related]
2. The prognostic value of aspartate aminotransferase-to-lymphocyte ratio index in early-stage hepatocellular carcinoma after hepatectomy: A propensity-score matched analysis.
Chen Y; He C; Wen T; Yan L; Yang J
Asia Pac J Clin Oncol; 2021 Oct; 17(5):e238-e248. PubMed ID: 33124200
[TBL] [Abstract] [Full Text] [Related]
3. Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative
Wu C; Cui Y; Zhao Y; Chen X; Liao X; Di L; Yin L; Liu M; Wang R
Eur J Radiol; 2020 Oct; 131():109218. PubMed ID: 32882538
[TBL] [Abstract] [Full Text] [Related]
4. Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma.
Li SC; Xu Z; Deng YL; Wang YN; Jia YM
Medicine (Baltimore); 2020 Jul; 99(27):e20919. PubMed ID: 32629689
[TBL] [Abstract] [Full Text] [Related]
5. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis.
Li J; Qin X; Wu R; Wan L; Zhang L; Liu R
J Cell Mol Med; 2020 May; 24(9):5152-5161. PubMed ID: 32222024
[TBL] [Abstract] [Full Text] [Related]
6. Modified Child-Pugh grade
Huang F; Gao J
World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
[TBL] [Abstract] [Full Text] [Related]
7. [Effect of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio on prognosis of patients with gastric cancer].
Han BL; Wang YM; Xue YW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):65-70. PubMed ID: 31958933
[No Abstract] [Full Text] [Related]
8. Nomogram to predict overall survival after gallbladder cancer resection in China.
Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of CpG island methylator phenotype among hepatocellular carcinoma patients: A systematic review and meta-analysis.
Wang Q; Wang G; Liu C; He X
Int J Surg; 2018 Jun; 54(Pt A):92-99. PubMed ID: 29698791
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.
Benetatos N; Hodson J; Marudanayagam R; Sutcliffe RP; Isaac JR; Ayuk J; Shah T; Roberts KJ
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):169-175. PubMed ID: 29576279
[TBL] [Abstract] [Full Text] [Related]
11. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases.
Ye L; Ye H; Zhou Q; Li Z; Lin Q; Tan L; Gao W; Fu Z; Zheng S; Chen R
Int J Surg; 2016 May; 29():108-17. PubMed ID: 27000717
[TBL] [Abstract] [Full Text] [Related]
12. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
[TBL] [Abstract] [Full Text] [Related]
13. [Meta-analysis of efficacy and safety of liver transplantation in treating cholangiocarcinoma].
Gu JY; Bai JL; Shi XL; Zhou JX; Qiu YD; Wu YF; Jiang CP; Sun XT; Xu FG; Zhang Y; Ding YT
Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):351-6. PubMed ID: 21612703
[TBL] [Abstract] [Full Text] [Related]
14. Upper aerodigestive tract and lung tumors after liver transplantation.
Jiménez C; Marqués E; Loinaz C; Romano DR; Gómez R; Meneu JC; Hernández-Vallejo G; Alonso O; Abradelo M; Garcia I; Moreno E
Transplant Proc; 2003 Aug; 35(5):1900-1. PubMed ID: 12962840
[TBL] [Abstract] [Full Text] [Related]
15. [Prevention of cirrhosis is the best measure against hepatocellular cancer].
Kaczynski J
Lakartidningen; 1999 Jan; 96(4):338-41. PubMed ID: 10024824
[TBL] [Abstract] [Full Text] [Related]
